/PRNewswire/ TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region,.
Future Market Insights projects that the paediatric clinical trials market sales will grow at a 5.3% annual pace between 2022 and 2032. From a projected US$ 15 billion in 2021 to a total valuation of US$ 26.47 billion by 2032, this market is anticipated to increase. The increase of chronic illnesses and genetic prob.
Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (NASDAQ:MLTX), has sold 60,000 shares of the company on February 20, 2024, according to a recent SEC Filing.
/PRNewswire/ The "Protein Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com s offering. In 2023, North America emerged as the.